Multidrug-resistant tuberculosis (TB) is caused by bacteria resistant to isoniazid and rifampicin, the two most effective first-line anti-TB drugs, originally developed and introduced in the 1950 and 1960s. This book presents the summary of a workshop convened to address the current status of drug-resistant TB globally and in China.